Preclin Biosystems AG specializes in providing a robust in vivo preclinical testing platform aimed at the identification and validation of lead candidate therapeutics. Their expertise lies in developing preclinical models that focus on chronic inflammatory and infectious diseases. The company offers a fully customizable service that aligns with the specific development goals of their clients. This includes detailed analysis of a drug's mechanism of action, determining the optimal route and regimen for administration, and assessing efficacy in targeted disease indications.

In addition to their preclinical testing services, Preclin Biosystems emphasizes the importance of safety assessment in drug development. Their comprehensive approach ensures that potential therapeutics are thoroughly evaluated for both effectiveness and safety before progressing to clinical trials. By leveraging their specialized knowledge in various disease models, Preclin Biosystems supports pharmaceutical and biotechnology companies in advancing their therapeutic candidates through the preclinical phase efficiently and effectively.

Switzerland

Preclin Biosystems is a biotechnology company that offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics.

Preclin Biosystems

Company Details